Check Out Why These 4 Stocks Spiked This Morning

Page 2 of 2

Horizon Pharma PLC (NASDAQ:HZNP) is up by over 5% today after issuing strong guidance for 2016. The small-cap Irish biopharmaceutical company said it expects full-year revenue of $1.03 billion-to-$1.05 billion, versus its previous guidance of between $950 million and $975 million. Management explained that the increased guidance sought to reflect the company’s acquisition of Crealta Holdings, which is expected to close this week.

Follow Horizon Therapeutics Public Ltd Co (NASDAQ:HZNP)

It appears that hedge funds really like Horizon Pharma PLC (NASDAQ:HZNP). 44 funds among those we keep track of held long stakes in the company as of the end of the third quarter, up from 43 a quarter earlier. Remarkably, these 44 firms owned roughly 35.7% of Horizon’s outstanding stock, with Stephen Mandel’s Lone Pine Capital holding almost 10% of the company’s shares alone, about 15.6 million in total.

Finally, there’s Aaron’s, Inc. (NYSE:AAN), which is up by about 7.7% percent in today’s trading session. No relevant news related to the company has surfaced today; however, on Monday afternoon, a press release informed that the retailer had presented four newly-renovated rooms to 400 teen members of the Keystone Club at the Hartley & Ruth Barker Branch of Boys & Girls Clubs of Greater Scottsdale.

Follow Aaron's Inc (NYSE:AAN)

Aaron’s, Inc. (NYSE:AAN) also sports plenty of hedge fund support. The number of funds that were long the stock rose by more than 10% during the third quarter, to 32. Even after a 12% reduction to its holding, Robert Rodriguez and Steven Romick’s First Pacific Advisors LLC held the largest position in the company among those investors we follow, comprising more than 1.58 million Aaron’s shares.

Disclosure: Javier Hasse holds no positions in any of the securities mentioned in this article.

Page 2 of 2